Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:acquisition |
Grifols
|
| gptkbp:awards |
safety awards
industry recognition innovation awards |
| gptkbp:clinicalTrials |
ongoing
autoimmune diseases neurological disorders efficacy studies safety studies bleeding disorders immune deficiencies patient trials infectious diseases treatment |
| gptkbp:collaborations |
government agencies
pharmaceutical companies biotech companies |
| gptkbp:community_involvement |
patient advocacy
health education charitable donations |
| gptkbp:employees |
approximately 1,500
|
| gptkbp:founded |
2005
|
| gptkbp:global_presence |
international markets
manufacturing facilities distribution networks |
| gptkbp:headquarters |
gptkb:Research_Triangle_Park,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
Talecris Biotherapeutics
|
| gptkbp:market |
biologics
therapeutic proteins plasma products |
| gptkbp:operates_in |
gptkb:Asia
gptkb:North_America Europe |
| gptkbp:parent_company |
gptkb:Grifols_S.A.
|
| gptkbp:partnerships |
academic institutions
research foundations healthcare_organizations |
| gptkbp:products |
albumin
hyperimmune globulin intravenous_immunoglobulin |
| gptkbp:regulatoryCompliance |
gptkb:FDA
EMA |
| gptkbp:research_focus |
neurology
hematology infectious diseases immunology |
| gptkbp:specializesIn |
plasma-derived therapies
|
| gptkbp:sustainability_initiatives |
energy efficiency
waste reduction water conservation environmental responsibility |
| gptkbp:website |
www.talecris.com
|